EQUITY - Narrative (Details)			3 Months Ended			12 Months Ended
		Apr. 20, 2023 tradingDay shares	Sep. 30, 2024 $ / shares	Jun. 30, 2024 $ / shares	Mar. 31, 2024 $ / shares	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 shares	Dec. 15, 2015 USD ($)
Stockholders' Equity Note [Line Items]
Common stock, shares authorized (in shares)						450,000,000	450,000,000
Common stock, par value (in dollars per share) | $ / shares						$ 0.01	$ 0.01
Common stock, shares issued (in shares)						52,309,209	52,248,631
Common stock, shares outstanding (in shares)						52,309,209	52,248,631
Stock repurchase program, authorized amount | $									$ 10,000,000
Preferred stock, shares authorized (in shares)						50,000,000	50,000,000
Preferred stock, par value (in dollars per share) | $ / shares						$ 0.01	$ 0.01
Preferred stock, shares issued (in shares)						2,400,000	2,400,000
Preferred stock, shares outstanding (in shares)						2,400,000	2,400,000
Dividends payable | $	[1]					$ 9,890,066	$ 4,654,904
Dividends declared per weighted average share of common stock (in dollars per share) | $ / shares			$ 0.08	$ 0.08	$ 0.07	$ 0.40	$ 0.26
Number of trading days | tradingDay		10
Stock Repurchase Program
Stockholders' Equity Note [Line Items]
Stock repurchase program, authorized amount | $									$ 10,000,000
Common stock shares repurchased (in shares)						0
Shares repurchased						126,856
Weighted average share price of common stock repurchased (in dollars per share) | $ / shares						$ 5.09
Common stock shares repurchased (in shares) | $						$ 9,400,000	$ 9,400,000
Common Stock
Stockholders' Equity Note [Line Items]
Common stock, shares outstanding (in shares)						52,309,209	52,248,631	52,231,152
Common Stock | Stock-for-Fees Program
Stockholders' Equity Note [Line Items]
Common stock issued (in shares)		2,611,555				60,578	17,479
Weighted average price | $ / shares						$ 2.4338	$ 2.2825
Common Stock | Stock-for-Fees Program | Director
Stockholders' Equity Note [Line Items]
Common stock issued (in shares)						522,311

[1] Our consolidated balance sheets include assets and liabilities of consolidated variable interest entities ("VIEs") as the Company was the primary beneficiary of these VIEs. As of December 31, 2024 and December 31, 2023, assets of the consolidated VIEs totaled $1,058,138,406 and $1,384,136,334, respectively and the liabilities of consolidated VIEs totaled $831,001,605 and $1,150,207,290, respectively. See Note 4 for further discussion.